ABC International

ABC International as an investment banking business flagship of Agricultural Bank of China Limited (ABC), ABC International Holdings Limited and its subsidiaries (ABCI) have top-quality professionals, rigorous governance structure and sound management. Based in Hong Kong and supported by the mainland, particularly through close co-operation with mainland branches, ABCI eyes international capital market and provides comprehensive and integrated financial services by drawing on ABC's powerful capital strength, good clientele base, comprehensive financial services and outstanding social reputation.

Wan Zhicheng

Director

Shaoqing Zhu

Assitant Vice President

26 past transactions

Chixin Semiconductor

Series A in 2025
Chixin Semiconductor is an IoT chip design company that specializes on low-power processors.

Coherent Biopharma

Series B in 2023
Coherent Biopharma is a pharmaceutical company focused on the development of innovative drug therapies for oncology and chronic diseases. The company utilizes its proprietary bi-targeting drug conjugation technology, which includes platforms such as BEST™, C-PROTAC, and a specific Chronic Diseases Platform. This advanced approach enables the creation of drugs that target multiple chronic conditions through tissue and organ site-specific delivery. Coherent Biopharma aims to enhance treatment options for patients by promoting the development of targeted therapies that address complex health challenges.

Excell Biology

Series B in 2023
Excell Biology is dedicated to addressing the biomedical industry's blockage and accomplishing the localization of essential raw materials. It offers customers biological medicine, cell, and gene therapy, and fundamental scientific research products and services of the quality and concentrates on three product sectors, including serum-free medium, fetal bovine serum, and identification reagents.

Southern Surveying and Mapping

Venture Round in 2023
Southern Surveying and Mapping is a surveying, mapping, and geographic information industry group integrating R&D, manufacturing, sales and technical services.

CanSemi

Private Equity Round in 2022
CanSemi is a semiconductor manufacturing company based in China, specializing in the production of microprocessors, power management chips, analog chips, and power discrete devices. The company operates as an integrated device manufacturer (IDM), focusing on addressing the domestic demand for chips in various sectors, including the Internet of Things, automotive electronics, industrial control, and 5G technology. By providing these essential components, CanSemi plays a significant role in supporting the growing technological landscape in China.

Voyah

Series A in 2022
Voyah creates and manufactures electric vehicle and automobile. It was founded in 2020 and is based in Hubei, China.

Hithium Energy Storage

Series B in 2022
Hithium is a tech enterprise, specializing in the R&D, production, and sales of lithium-ion battery core materials, LFP energy storage batteries, and systems. Hithium's inventions include unprecedented safety advancements to its lithium-ion batteries as well as gains in a lifetime, thanks to four R&D centers and various intelligent production facilities.

Coherent Biopharma

Series B in 2022
Coherent Biopharma is a pharmaceutical company focused on the development of innovative drug therapies for oncology and chronic diseases. The company utilizes its proprietary bi-targeting drug conjugation technology, which includes platforms such as BEST™, C-PROTAC, and a specific Chronic Diseases Platform. This advanced approach enables the creation of drugs that target multiple chronic conditions through tissue and organ site-specific delivery. Coherent Biopharma aims to enhance treatment options for patients by promoting the development of targeted therapies that address complex health challenges.

Winicssec

Venture Round in 2022
Winicssec is a Beijing-based provider of security products and services for industrial control systems, focusing on enhancing the safety of China's infrastructure network. The company specializes in developing industrial safety solutions and offers a comprehensive range of services, including training, consulting, evaluation, construction, operation, and maintenance related to process safety. By delivering these multi-industry services, Winicssec enables its clients to ensure the secure operation of critical cybersecurity infrastructure across various sectors.

JA SOLAR

Post in 2022
JA Solar Holdings Co., Ltd. is a world-leading manufacturer of high-performance solar power products that convert sunlight into electricity for residential, commercial, and utility-scale power generation. The company is committed to develop and provide the world with clean and renewable energy to ease the energy shortages as well as human kind’s impact on the environment.

China Resources Vanguard

Funding Round in 2022
China Resources Vanguard, doing business as China Resources Vanguard Shop or Vanguard, operates the supermarket chains of China Resources. It is the third-largest supermarket chain in Hong Kong. As of December 31, 2014, there are 4866 shops operating in Hong Kong and the mainland Chinese provinces/municipalities of Guangdong, Zhejiang, Jiangsu, Shanghai, Tianjin and Beijing. According to market research firm EuroMonitor's estimates in 2012, China Resources Vanguard supermarket market share in Hong Kong is about 7.8%. Wellcome Hong Kong's market share is about 39.8% and PARKnSHOP Hong Kong's market share is about 33.1%. On August 18, 2013, China Resources Enterprise's supermarket chain Vanguard and British supermarket Tesco signed a "memorandum of understanding", intending to set up a joint venture interest group in mainland China, Hong Kong and Macau, operating hypermarkets, supermarkets, convenience stores, liquor stores and cash and carry businesses. China Resources Enterprise took an 80% share and Tesco took a 20% share.

Hong Kong Asia Heart Centre

Series D in 2022
Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.

Xinjunte

Series B in 2021
Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Kangpu Biopharmaceuticals

Series B in 2021
Kangpu Biopharmaceuticals is a clinical-stage company dedicated to the discovery and development of small molecule drugs aimed at treating cancer, autoimmune diseases, and inflammatory disorders. The company leverages proprietary technologies that focus on the modulation of ubiquitin-protein interactions to create innovative medical treatments. Additionally, Kangpu employs a drug discovery platform known as X-Synergy®, which enhances its capabilities in developing targeted therapies. By utilizing novel approaches such as targeted protein ubiquitination and degradation, Kangpu aims to deliver effective medical solutions that improve patient health outcomes.

B-One

Series B in 2021
B-One is a manufacturer of artificial joints.

Fukey Technology

Series A in 2021
Fukey Technology is a payment and marketing company that helps merchants with centralized cashier and integrated billing functions.

WuXi Diagnostics

Series B in 2021
WuXi Diagnostics builds an innovative model that enables diagnostic product innovation, generates clinical insights, and benefits the health of mankind through precision diagnosis and treatment.

Sinovent

Venture Round in 2020
Sinovent Inc. is a biopharmaceutical company established in 2016, with its headquarters in Suzhou, China, and additional offices in Beijing and Boston. The company focuses on developing innovative treatment methods through its advanced biotechnology platform and extensive management experience. Sinovent aims to address global healthcare challenges by combining expertise in science, management, and finance. Currently, it has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases.

SFCC

Series A in 2020
SFCC provides a mass commercial operation of hydrogen fuel cell vehicles. The company is a hydrogen fuel cell technology research, power system research and development and industrialization, and a national high-tech enterprise with independent innovation core technologies. SFCC was established on April 8, 2016 in Shenzhen, Guangdong.

Huaxianbang

Series B in 2019
Huaxianbang is a platform dedicated to providing Internet + services for chemical fiber trading. It provides a one-stop service system, including trading, finance, logistics, data services, chemical fiber peripherals (accessories), etc., allowing chemical fiber customers to enjoy 360-degree customer value and Experience, create a fair, transparent, timely, effective and high-quality chemical fiber service platform for all users of the chemical fiber industry. At present, it has obtained tens of millions of RMB investment from two well-known international investment companies.

CGeneTech

Series A in 2019
CGeneTech is being developed for the production and distribution of synthetic DNA purification kits for use in research and medicine. They provide services including selling ODN purification kits, custom synthesis, lead optimization, and library design and synthesis.

Sunmi

Series C in 2019
Shanghai Sunmi Technology Co., Ltd is a technology-driven company that specializes in intelligent commercial hardware solutions for the online-to-offline (O2O) market. The firm develops smart point-of-sale devices, including handheld and desktop payment terminals, which operate on their proprietary Android-based payment system. These devices are designed to enhance the transaction process for businesses, offering a secure and efficient means for clients to digitize their operations. Sunmi aims to support O2O platforms and software developers by providing high-quality, cost-effective hardware that meets the demands of the mobile internet age. With a focus on integrating supply chains and collaborating with internet resources, Sunmi aspires to deliver significant value to its partners and contribute to the evolution of commercial practices. The company has attracted substantial investment from notable tech firms, underscoring its position in the commercial application sector.

WeRide

Series A in 2019
WeRide is a leading, commercial-stage global company that develops Level 4 autonomous driving technologies. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable and accessible. WeRide is conducting autonomous driving R&D, tests and operations in over 25 cities around the world. As the pioneer leader in autonomous technologies and services, WeRide has stepped up to the commercial stage in operations. WeRide offers an all-rounded product mix of Robotaxi, Robobus, Robovan, Robosweeper and ADAS, providing smart services in online ride-hailing, on-demand transport, urban logistics, sanitation services and acting as a solution provider. Established in 2017, WeRide is headquartered in Guangzhou, China, and has expanded its R&D and operation centers to Beijing, Shanghai, Shenzhen, Zhengzhou, Nanjing, Wuhan, and Anqing, as well as San Francisco in the US. WeRide has formed strategic partnerships with leading global OEMs and Tier 1 supplier including Renault-Nissan-Mitsubishi Alliance, Yutong Group, GAC Group, Bosch, etc.

Suning.com

Series A in 2018
Suning.com is a prominent Chinese online shopping platform that offers a wide range of products, including clothing, snacks, electronics, and appliances. The company emphasizes a comprehensive retail experience by integrating smart retail solutions with full category operations and omni-channel services, enabling customers to shop seamlessly through physical stores, mobile devices, PCs, and TVs. Additionally, Suning.com leverages logistics and global expansion strategies to enhance its service offerings. Founded in 1990, Suning Holdings Group, which includes Suning.com, has established itself as a leading commercial enterprise in China, recognized for its significant annual revenue and diverse business interests across various sectors, including logistics, financial services, and media. Suning's commitment to improving the quality of life through technological advancements and innovative retail solutions underscores its influence in the retail landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.